|
KR20180052541A
|
|
Method for enhancing effect of immunotherapy for cancer
|
|
EP3299373A2
|
|
Medicarpin, its derivatives, manufacturing method thereof
|
|
TW201906624A
|
|
Use of astragalus membranaceus extract in manufacture composition for inhibiting melanogenesis
|
|
CN109199907A
|
|
Radix Astragali extract is preparing the application in the composition for inhibiting melanin production
|
|
TW201725041A
|
|
The pharmaceutical composition for reduction of skin irritation
|
|
TW201815404A
|
|
A astragalus medicinal compositions to prevent and treat the aging and use thereof
|
|
CN106456688A
|
|
A composition comprising astragalus membranaceus extract for preventing/treating brain injury and a preparation method thereof
|
|
EP2376096A2
|
|
Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
|
|
CN102170894A
|
|
A pharmaceutical composition with the effect of treating diabetes
|
|
MY156331A
|
|
Pharmaceutical composition for treating diabetes
|
|
TW201041587A
|
|
A pharmaceutical composition for enhancing insulin sensitivity and treating diabetes
|
